A new consensus document from the American College of Rheumatology guides rheumatologists on screening, assessment, and collaboration methods to manage atherosclerotic cardiovascular disease in patients with rheumatoid arthritis, according to a report published by Medscape.
Eighteen draft statements from the document were unveiled at the American College of Rheumatology 2026 Annual Meeting, according to Medscape. Stakeholders emphasized that the full document is not intended as a formal set of guidelines and will not be available until early to mid-2027, according to Medscape.
The recommendations cover topics ranging from obtaining a lipid profile to performing atherosclerotic cardiovascular disease risk assessments within a year of a rheumatoid arthritis diagnosis, according to Medscape. Interprofessional communication emerged as a central theme in the document, according to Medscape.
Jon Giles, MD, MPH, director of the Inflammatory Arthritis Clinical Center at Cedars-Sinai, presented findings from a study of more than 24,000 patients with rheumatoid arthritis, according to Cedars-Sinai Experts Share Rheumatology Research at ACR 2026.
The study found that cholesterol-lowering statins were underused, even among patients with established cardiovascular disease, according to Cedars-Sinai Experts Share Rheumatology Research at ACR 2026. Giles is also part of the committee presenting the newly developed recommendations for cardiovascular disease screening and management, according to Cedars-Sinai Experts Share Rheumatology Research at ACR 2026.
“Patients with rheumatoid arthritis face an increased risk of heart disease, yet too many are missing out on treatments that could help protect them,” Giles said, according to Cedars-Sinai Experts Share Rheumatology Research at ACR 2026. “These findings highlight the need for rheumatologists to work closely with cardiovascular specialists to ensure patients receive appropriate care.”
The first draft statement states that rheumatologists should collaborate with primary care providers and cardiologists in detecting and managing cardiovascular disease risk in adult patients with rheumatoid arthritis, according to Medscape. At the same time, the document calls on rheumatologists to take a more deliberate role in patient cardiovascular health, according to Medscape.
Solomon also said that statements on risk score assessment and imaging were particularly important, adding that new tools and technologies have created interest among rheumatologists regarding how to apply these new management strategies in patients with rheumatoid arthritis, according to Medscape.
The American College of Rheumatology, known until 1985 as the American Rheumatism Association, is an organization of physicians, health professionals and scientists that advances rheumatology through education, research, advocacy and practice support. It organizes scientific meetings such as the annual gathering where the cardiovascular consensus draft was unveiled, and publishes three medical journals including Arthritis & Rheumatology and Arthritis Care & Research.
Heba Wassif, MD, MPH, a clinical cardiologist and director of Inpatient Clinical Cardiology in the Tomsich Family Department of Cardiovascular Medicine at the Cleveland Clinic, called the consensus statements overdue, according to Medscape. She said that awareness of the connection between rheumatoid arthritis and cardiovascular risks traces back to a 1953 report in The New England Journal of Medicine, according to Medscape.